Eton Pharmaceuticals (ETON) Operating Margin (2019 - 2025)

Eton Pharmaceuticals has disclosed Operating Margin across 7 years of filings, most recently posting 11.05% for Q4 2025.

• Operating Margin for Q4 2025 came in at 11.05%, down 978.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 1.48% (up 57.0% YoY), and the FY2025 annual result was 1.2%, up 85.0% from the prior year.
• Operating Margin came in at 11.05% for Q4 2025 at Eton Pharmaceuticals, up from 6.07% in the prior quarter.
• In the past five years, Operating Margin ranged from a high of 87.41% in Q4 2022 to a low of 754.45% in Q3 2021.
• The 5-year median for Operating Margin is 7.8% (2023), against an average of 55.12%.
• Peak annual rise in Operating Margin reached 2261419 bps in 2021, while the deepest fall reached 24731177 bps in 2021.
• Eton Pharmaceuticals' Operating Margin stood at 21.57% in 2021, then soared by 305 bps to 87.41% in 2022, then tumbled by 108 bps to 6.69% in 2023, then soared by 411 bps to 20.83% in 2024, then slumped by 47 bps to 11.05% in 2025.
• The last three Operating Margin figures came in at 11.05% (Q4 2025), 6.07% (Q3 2025), and 7.79% (Q2 2025), per Business Quant data.